International Alliance for Biological Standardization

Select Page

SCIENTIFIC EVENTS

Enabling the Evaluation of COVID-19 Vaccines with Correlates of Protection
A Hybrid Meeting

February 16 – 17, 2023

4th Controlled Human Infection Model (CHIM) Meeting
Mombasa, Kenya
.
.
.
May 22-25, 2023

Informations will be available soon

Maintening the Quality of Vaccines through the Use of References Standards Current Challenges and Future Opportunities

June 21 – June 22, 2023

9th Annual Statistics Workshop
Statistical Innovation Advancing CMC

November 2023

NEWS

ADVAC

Message from IABS President

Dear IABS Colleagues,
The onset of the holiday season and the calendar switch to the new year is a perfect time to reflect on IABS’ highly successful 2022! After transitioning to webinars and elect…

Read more

President’s Column 2022

Dear IABS Colleagues, Stakeholders, Supporters, and Collaborators,
It was an honor to assume the presidency of this prestigious organization in 2022.  IABS has a celebrated history, and I am looking forward to more accomplishments…

Read more

What does IABS do that is unique ?

In this short interview, Joris Vandeputte, former President of IABS has answered the question “What does IABS do that is unique ?”
To learn more about the International Alliance for Biological…

Read more

IABS COLLABORATIONS

INNOVATIVE MEDICINES INITIATIVE (IMI) PROJECTS :

IMI is a European public-private partnership aiming to speed up the development of better and safer medicines. IMI is partly founded by the European Commission.

The IABS European Affiliate (IABS-EU) was part of consortia which have  been selected by IMI to be the public partners of following consortia.

IABS-EU was selected to drive the regulatory part of those consortia.

IABS COLLABORATIONS / MANCO, A EUROPEAN COMMISSION PROJECT :

MANCO (Monclonal Antibodies against COVID-19) is one of the eighteen projects that have been successfully selected by the European Commission, which is devoted to the development of Monoclonal Antibodies agains COVID-19.

IABES-EU was selected to drive the regulatory part of the project

TESTIMONIALS

Paul Henri Lambert

Professor at University of Geneva
Founder of ADVAC

 “I have appreciated the achievements of IABS since many years. It is a unique independent organization that can…

Read more

John Petricciani

Past President
Advisor to the Board

“ Cell substrates have been a key element in the evolution of biological products since the…

Read more

Kathryn Zoon

NIH Scientist Emeritus
Past NIAID Scientific Director

As a long term US regulator and scientist, I have been working with IABS for many years. The IABS has …

Read more

Philippe Duclos

Director ADVAC
University of Geneva

“ A vibrant organization that allows dialogue beyond professional boundaries…

Read more